首页> 外文期刊>Nature Communications >Structure–function insights reveal the human ribosome as a cancer target for antibiotics
【24h】

Structure–function insights reveal the human ribosome as a cancer target for antibiotics

机译:结构-功能洞察揭示了人类核糖体是抗生素的癌症靶标

获取原文
           

摘要

Many antibiotics in clinical use target the bacterial ribosome by interfering with the protein synthesis machinery. However, targeting the human ribosome in the case of protein synthesis deregulations such as in highly proliferating cancer cells has not been investigated at the molecular level up to now. Here we report the structure of the human 80S ribosome with a eukaryote-specific antibiotic and show its anti-proliferative effect on several cancer cell lines. The structure provides insights into the detailed interactions in a ligand-binding pocket of the human ribosome that are required for structure-assisted drug design. Furthermore, anti-proliferative dose response in leukaemic cells and interference with synthesis of c-myc and mcl-1 short-lived protein markers reveals specificity of a series of eukaryote-specific antibiotics towards cytosolic rather than mitochondrial ribosomes, uncovering the human ribosome as a promising cancer target.
机译:临床上使用的许多抗生素通过干扰蛋白质合成机制来靶向细菌核糖体。然而,迄今为止,尚未在分子水平上研究在蛋白质合成失调的情况下(例如在高度增殖的癌细胞中)靶向人核糖体。在这里,我们报道了具有真核生物特异性抗生素的人类80S核糖体的结构,并显示了其对几种癌细胞系的抗增殖作用。该结构提供了对结构辅助药物设计所需的人核糖体配体结合口袋中详细相互作用的深入了解。此外,白血病细胞中的抗增殖剂量反应以及对c-myc和mcl-1短期蛋白质标记合成的干扰揭示了一系列真核生物特异性抗生素对胞质而非线粒体核糖体的特异性,从而揭示了人类核糖体有希望的癌症目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号